Reik & Co., LLC Pfizer Inc Transaction History

Reik & Co., LLC

$399 Million
Q3 2024

A detailed history of Reik & Co., LLC transactions in Pfizer Inc stock. As of the latest transaction made, Reik & Co., LLC holds 25,836 shares of PFE stock, worth $668,894. This represents 0.19% of its overall portfolio holdings.

Number of Shares

25,836

Previous 25,836 -0.0%

Holding current value

$668,894

Previous $722,000 3.46%

% of portfolio

0.19%

Previous 0.18%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	BUY	$25.89 - $29.73 $51,780 - $59,460	2,000 Added 8.39%	25,836 $716,000
Q4 2023 Jan 26, 2024	BUY	$26.13 - $33.94 $109,118 - $141,733	4,176 Added 21.24%	23,836 $686,000
Q3 2023 Nov 06, 2023	BUY	$32.09 - $37.51 $30,838 - $36,047	961 Added 5.14%	19,660 $652,000
Q1 2023 May 10, 2023	SELL	$39.39 - $51.28 $29,975 - $39,024	-761 Reduced 3.91%	18,699 $762,000
Q2 2020 Aug 05, 2020	BUY	$30.12 - $36.54 $9,036 - $10,962	300 Added 1.57%	19,460 $636,000
Q1 2020 Apr 29, 2020	BUY	$27.03 - $38.62 $7,162 - $10,234	265 Added 1.4%	19,160 $625,000
Q2 2019 Jul 29, 2019	BUY	$36.98 - $41.52 $25,516 - $28,648	690 Added 3.79%	18,895 $819,000
Q2 2018 Aug 06, 2018	SELL	$32.98 - $35.16 $7,750 - $8,262	-235 Reduced 1.27%	18,205 $660,000
Q1 2018 Apr 25, 2018	BUY	$31.91 - $37.02 $32,388 - $37,575	1,015 Added 5.82%	18,440 $654,000
Q4 2017 Jan 31, 2018	BUY	$33.26 - $35.29 $79,824 - $84,696	2,400 Added 15.97%	17,425 $631,000
Q3 2017 Oct 26, 2017	BUY	$31.0 - $34.15 $465,775 - $513,103	15,025	15,025 $536,000

Others Institutions Holding PFE

# of Institutions

3,261

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $145B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Reik & Co., LLC, based on Form 13F filings with the SEC.

News

Stay updated on Reik & Co., LLC with notifications on news.

Account